Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Leukemia × Ribavirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Hepatitis C 4 Carcinoma, Hepatocellular 4 Recurrence 3 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Respiratory Tract Infections 2 Lymphoma, Mantle-Cell 2 Leukemia, Myeloid, Acute 2 Infections 2 Hepatitis C, Chronic 2 Head and Neck Neoplasms 2 Breast Neoplasms 2 Wilms Tumor 1 Testicular Neoplasms 1 Teratoma, Testicular 1 Teratoma 1 Seminoma 1 Respiratory Syncytial Virus Infections 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Precancerous Conditions 1 Pneumonia 1 Neuroblastoma 1 Neoplasms, Squamous Cell 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Malignant Solid Tumor 1 Lymphoma, T-Cell, Cutaneous 1

Interventions

Cyclophosphamide 235 Cytarabine 148 fludarabine phosphate 142 Methotrexate 114 Filgrastim 100 Busulfan 98 fludarabine 90 Rituximab 89 Peripheral Blood Stem Cell Transplantation 80 Etoposide 78 Antilymphocyte Serum 73 Cyclosporine 68 Whole-Body Irradiation 67 Radiotherapy 65 Mycophenolic Acid 64 Melphalan 62 Tacrolimus 60 Vincristine 52 Dexamethasone 49 Methylprednisolone 44 Granulocyte Colony-Stimulating Factor 41 Azacitidine 40 Imatinib Mesylate 38 Idarubicin 36 Alemtuzumab 35 Clofarabine 34 Mercaptopurine 33 Cord Blood Stem Cell Transplantation 33 Daunorubicin 32 sargramostim 31

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00559091 2022-12-22

Borden-001

Jewish General Hospital

Phase 2 Completed

Other hematologic neoplasm

Leukemia, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡